Characteristics of Mpox Infections in Louisiana in the 2022 Outbreak.


Journal

AIDS research and human retroviruses
ISSN: 1931-8405
Titre abrégé: AIDS Res Hum Retroviruses
Pays: United States
ID NLM: 8709376

Informations de publication

Date de publication:
11 2023
Historique:
pmc-release: 01 11 2024
medline: 6 11 2023
pubmed: 10 7 2023
entrez: 10 7 2023
Statut: ppublish

Résumé

The 2022 outbreak of mpox in Louisiana was limited to just >300 cases, perhaps an unexpected outcome given the state's high rates of HIV and other sexually transmitted infections (STIs). We aimed to describe the local outbreak within two health centers in the New Orleans region, partnering with the Louisiana Department of Health to offer additional statewide data. We reviewed charts of persons testing positive for mpox in New Orleans from July to November 2022 at two local health centers that together accounted for half of local cases. We abstracted data on HIV status, immune function [CD4 count, viral load (VL)], antiretroviral therapy regimen, symptoms and severity of infection, vaccination status, and whether tecovirimat was administered. We present local data relative to statewide data (July 2022-January 2023). Of 103 individuals in our network for whom charts were reviewed, 96 (93%) identified as male, 52 (50%) were Black, and 69 (67%) had HIV, including 12 (17%) with uncontrolled HIV (CD4 < 200 cells/mm

Identifiants

pubmed: 37424520
doi: 10.1089/AID.2023.0011
pmc: PMC10621655
doi:

Types de publication

Review Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

587-592

Subventions

Organisme : NIAID NIH HHS
ID : K23 AI137121
Pays : United States

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
MMWR Morb Mortal Wkly Rep. 2022 Dec 09;71(49):1560-1564
pubmed: 36480479
Clin Infect Dis. 2023 Apr 17;76(8):1508-1512
pubmed: 36546646
Lancet. 2023 Mar 18;401(10380):939-949
pubmed: 36828001
Clin Infect Dis. 2023 Apr 17;76(8):1504-1507
pubmed: 36546644
MMWR Morb Mortal Wkly Rep. 2022 Nov 11;71(45):1449-1456
pubmed: 36355615
MMWR Morb Mortal Wkly Rep. 2022 Nov 04;71(44):1412-1417
pubmed: 36327164
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Curr HIV/AIDS Rep. 2023 Aug;20(4):261-269
pubmed: 37178205
J Med Virol. 2023 Feb;95(2):e28534
pubmed: 36708091
Cell. 2021 Sep 16;184(19):4939-4952.e15
pubmed: 34508652
MMWR Morb Mortal Wkly Rep. 2022 Oct 28;71(43):1379-1381
pubmed: 36301814
MMWR Morb Mortal Wkly Rep. 2022 Dec 30;71(5152):1610-1615
pubmed: 36580416

Auteurs

Nabil M Essajee (NM)

Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.

Hope Oddo-Moise (H)

Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.

Michael E Hagensee (ME)

Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.

Rebecca A Lillis (RA)

Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.

Joanne Maffei (J)

Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.

Isolde Butler (I)

CrescentCare Federally Qualified Health Center, New Orleans, Louisiana, USA.

Aish Lovett (A)

Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.

Theresa Sokol (T)

Office of Public Health, Louisiana Department of Health, New Orleans, Louisiana, USA.

Meredith E Clement (ME)

Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH